Usefulness of GnRH Antagonist Administration in the Treatment of Early Ovarian Hyperstimulation Syndrome.
Phase of Trial: Phase III
Latest Information Update: 18 Sep 2013
At a glance
- Drugs Cetrorelix; Ganirelix
- Indications Ovarian hyperstimulation syndrome
- Focus Biomarker; Therapeutic Use
- 30 Mar 2012 Planned end date changed from 1 Jun 2011 to 1 Aug 2012 as reported by ClinicalTrials.gov.
- 28 Jun 2011 New source identified and integrated (European Clinical Tials Database)
- 06 Jan 2011 New trial record